Biotech SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 4, 2021
Biotech DEADLINE ALERT for FBIO, SPLK, BSX, and QIWI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders January 4, 2021
Biotech Ampio Provides Update on Clinical Trials for Ampion(TM) Treatment of COVID-19 Patients January 4, 2021
Biotech ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV(TM) January 4, 2021
Biotech Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January January 4, 2021
Biotech Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference January 4, 2021
Biotech Ayala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 Study January 4, 2021